期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 10, 期 11, 页码 1512-1517出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.9b00409
关键词
Drug discovery; photocycloaddition; sp(3)-rich scaffolds; hit and lead generation
资金
- Engineering and Physical Sciences Research Council [EP/P013341/1]
- EPSRC [EP/P013341/1] Funding Source: UKRI
Pressure on researchers to deliver new medicines to the patient continues to grow. Attrition rates in the research and development process present a significant challenge to the viability of the current model of drug discovery. Analysis shows that increasing the three-dimensionality of potential drug candidates decreases the risk of attrition, and it is for this reason many workers have taken a new look at the power of photochemistry, in particular photocycloadditions, as a means to generate novel sp(3)-rich scaffolds for use in drug discovery programs. The viability of carrying out photochemical reactions on scale is also being addressed by the introduction of new technical developments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据